<?phpxml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
>
<channel>
<title>Dofollow Social Bookmarking Sites 2016 / kmsantosh / Published News</title>
<link>http://www.apparent.sblinks.net</link>
<description>Your Source for Social News and Networking</description>
<pubDate>Thu, 07 Mar 2024 12:07:15 +0000</pubDate>
<language>en</language>
<item>
	<title><![CDATA[Clinical Trial Logistics]]></title>
	<link>http://www.apparent.sblinks.net/News/clinical-trial-logistics/</link>
	<source url="http://www.apparent.sblinks.net/News/clinical-trial-logistics/"><![CDATA[Clinical Trial Logistics]]></source>
	<description><![CDATA[ Plants, animals, and humans all have germline cells, which are vital but incredibly delicate cells that retain DNA from all generations. With the help of the powerful CRISPR/Cas9 gene-editing technique, these cells can now be altered. The unique approach relies on controlling the expression of particular genes in germ cells by means of RNA. This molecular "CRISPR-on-a-chip" assay may even be helpful against the relatively old retroviruses that cause cystic fibrosis in some people, according to a recent study published in the journal Molecular Cell.<br /><br />It should be made clear that this is not a way to attempt and treat hereditary diseases, but even so, this is an incredible finding.  ]]></description>
	<pubDate>Thu, 07 Mar 2024 12:07:15 +0000</pubDate>
	<author>kmsantosh</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.apparent.sblinks.net/News/clinical-trial-logistics/</guid>
</item>

<item>
	<title><![CDATA[Pharma Logistics]]></title>
	<link>http://www.apparent.sblinks.net/News/pharma-logistics/</link>
	<source url="http://www.apparent.sblinks.net/News/pharma-logistics/"><![CDATA[Pharma Logistics]]></source>
	<description><![CDATA[ Plants, animals, and humans all have germline cells, which are vital but incredibly delicate cells that retain DNA from all generations. With the help of the powerful CRISPR/Cas9 gene-editing technique, these cells can now be altered. The unique approach relies on controlling the expression of particular genes in germ cells by means of RNA. This molecular "CRISPR-on-a-chip" assay may even be helpful against the relatively old retroviruses that cause cystic fibrosis in some people, according to a recent study published in the journal Molecular Cell.<br /><br />It should be made clear that this is not a way to attempt and treat hereditary diseases, but even so, this is an incredible finding.  ]]></description>
	<pubDate>Thu, 07 Mar 2024 12:05:27 +0000</pubDate>
	<author>kmsantosh</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.apparent.sblinks.net/News/pharma-logistics/</guid>
</item>

</channel>
</rss>
